Last Name


Search Results to Laura Ramsey

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Ramsey, Laura

keywords Pharmacogenetics
keywords Pharmacogenomics
research overview Dr. Ramsey joined Children’s Mercy in 2023 as the Section Chief of Individualized Therapeutics in the Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation. She is leading the implementation of a pharmacogenomics program that is fully integrated with the electronic health record, and she is developing model-informed decision support for several medications. Before joining Children’s Mercy, Dr. Ramsey was an Associate Professor at Cincinnati Children’s Hospital Medical Center, co-director of the Genetic Pharmacology Service, and co-director of the Clinical Pharmacology Fellowship program. She completed her postdoctoral fellowship in Pharmacogenetics at St. Jude Children’s Research Hospital and received her PhD in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota – Twin Cities. Dr. Ramsey is interested in all aspects of pharmacogenetics, from basic research to implementation in patient care. She has led projects to study pharmacogenetic variants that influence response, toxicity, and dosing of antidepressants, immunosuppressants, and chemotherapy in children. She has authored over 100 peer-reviewed manuscripts, hundreds of abstract presentations, and is extramurally funded, including a National Institutes of Health R01 award.

One or more keywords matched the following items that are connected to Ramsey, Laura

Item TypeName
Academic Article A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
Academic Article Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics.
Academic Article The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Academic Article PharmVar GeneFocus: SLCO1B1.
Academic Article Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens.
Academic Article Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
Academic Article Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition.
Academic Article The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
Academic Article Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.
Academic Article The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
Academic Article Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia.
Academic Article Pharmacogenomic Testing in Child and Adolescent Psychiatry: An Evidence-Based Review.
Academic Article Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine.
Academic Article Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
Academic Article Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.
Academic Article Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
Academic Article Gene-Based Dose Optimization in Children.
Academic Article Pharmacogenetics of treating pediatric anxiety and depression.
Academic Article Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care.
Academic Article CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
Academic Article Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
Academic Article Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
Academic Article Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
Academic Article Planning and Conducting a Pharmacogenetics Association Study.
Academic Article The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents.
Academic Article Toward pharmacogenetic SLCO1B1-guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model.
Academic Article Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Academic Article Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.
Academic Article Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
Academic Article Editorial: Beyond Red Light, Green Light: Examining the Role of Pharmacogenomics in Evidence-Based Care in Child and Adolescent Psychiatry.
Academic Article Implementation of CYP2D6-guided opioid therapy at Cincinnati Children's Hospital Medical Center.
Academic Article Current Practices in Pharmacogenomics.
Grant Identifying Pharmacogenomic Predictors of Methotrexate Response and Metabolite Biotransformation in JIA
Academic Article Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study.

Search Criteria
  • Developmental
  • Pharmacogenomics